Advanced search
Publication Cover
OncoImmunology Volume 4, 2015 - Issue 5
Submit an article Journal homepage
782
Views
13
CrossRef citations to date
0
Altmetric
Author's View

Restoration of defective cross-presentation in tumors by gemcitabine

Alison M McDonnellSchool of Medicine and Pharmacology; The University of Western Australia; Nedlands, WA, Australia;National Centre for Asbestos Related Diseases; Nedlands, WA, AustraliaCorrespondence[email protected]
,
W Joost LesterhuisSchool of Medicine and Pharmacology; The University of Western Australia; Nedlands, WA, Australia;National Centre for Asbestos Related Diseases; Nedlands, WA, Australia
,
Andrea KhongSchool of Medicine and Pharmacology; The University of Western Australia; Nedlands, WA, Australia;National Centre for Asbestos Related Diseases; Nedlands, WA, Australia
,
Anna K NowakSchool of Medicine and Pharmacology; The University of Western Australia; Nedlands, WA, Australia;National Centre for Asbestos Related Diseases; Nedlands, WA, Australia;Department of Medical Oncology; Sir Charles Gairdner Hospital; Nedlands, WA, Australia
,
Richard A LakeSchool of Medicine and Pharmacology; The University of Western Australia; Nedlands, WA, Australia;National Centre for Asbestos Related Diseases; Nedlands, WA, Australia
,
Andrew J CurrieSchool of Medicine and Pharmacology; The University of Western Australia; Nedlands, WA, Australia;School of Veterinary and Life Sciences, Murdoch University, Murdoch, WA, Australia
&
Bruce WS RobinsonSchool of Medicine and Pharmacology; The University of Western Australia; Nedlands, WA, Australia;National Centre for Asbestos Related Diseases; Nedlands, WA, Australia
 show all
Article: e1005501 | Received 28 Dec 2014, Accepted 30 Dec 2014, Published online: 21 May 2015

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Mariona Cabo, Rienk Offringa, Laurence Zitvogel, Guido Kroemer, Aura Muntasell & Lorenzo Galluzzi. (2017) Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications. OncoImmunology 6:12.
Read now
Claire Vanpouille-Box, Claire Lhuillier, Lucillia Bezu, Fernando Aranda, Takahiro Yamazaki, Oliver Kepp, Jitka Fucikova, Radek Spisek, Sandra Demaria, Silvia C. Formenti, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2017) Trial watch: Immune checkpoint blockers for cancer therapy. OncoImmunology 6:11.
Read now
Delia J. Nelson, Briony Clark, Kylie Munyard, Vincent Williams, David Groth, Jespal Gill, Henry Preston & Arlene Chan. (2017) A review of the importance of immune responses in luminal B breast cancer. OncoImmunology 6:3.
Read now

Articles from other publishers (10)

Qingxin Fan, Jing Zuo, Hailong Tian, Canhua Huang, Edouard C. Nice, Zheng Shi & Qingquan Kong. (2022) Nanoengineering a metal–organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Jingyang Liu, Yang Yu, Cun Liu, Chundi Gao, Jing Zhuang, Lijuan Liu, Qibiao Wu, Wenzhe Ma, Qiming Zhang & Changgang Sun. (2022) Combinatorial regimens of chemotherapeutic agents: A new perspective on raising the heat of the tumor immune microenvironment. Frontiers in Pharmacology 13.
Crossref
Bruce W.S. Robinson, Alec J. Redwood & Jenette Creaney. (2022) How Our Continuing Studies of the Pre-clinical Inbred Mouse Models of Mesothelioma Have Influenced the Development of New Therapies. Frontiers in Pharmacology 13.
Crossref
Pankaj Ahluwalia, Meenakshi Ahluwalia, Ashis K. Mondal, Nikhil S. Sahajpal, Vamsi Kota, Mumtaz V. Rojiani & Ravindra Kolhe. (2021) Natural Killer Cells and Dendritic Cells: Expanding Clinical Relevance in the Non-Small Cell Lung Cancer (NSCLC) Tumor Microenvironment. Cancers 13:16, pages 4037.
Crossref
Richard Hopkins, Wenwei Xiang, Damien Marlier, Veonice Bijin Au, Qianting Ching, Lynn Xue Wu, Rujun Guan, Bernett Lee, Whay-Kuang Chia, Who-Whong Wang, Joseph Wee, Joanna Ng, Rachael Cheong, Shuting Han, Axel Chu, Chit Lai Chee, Timothy Shuen, Michael Podinger, Alexander Lezhava, Han Chong Toh & John E. Connolly. (2021) Monocytic Myeloid-Derived Suppressor Cells Underpin Resistance to Adoptive T Cell Therapy in Nasopharyngeal Carcinoma. Molecular Therapy 29:2, pages 734-743.
Crossref
Zahra Gholizadeh, Jalil Tavakkol-Afshari, Amin Reza Nikpoor, Seyed Amir Jalali & Mahmoud Reza Jaafari. (2018) Enhanced immune response induced by P5 HER2/neu-derived peptide-pulsed dendritic cells as a preventive cancer vaccine. Journal of Cellular and Molecular Medicine 22:1, pages 558-567.
Crossref
Jonathan Chee, Bruce W.S. Robinson, Robert A. Holt & Jenette Creaney. (2017) Immunotherapy for Lung Malignancies. Chest 151:4, pages 891-897.
Crossref
Guido Kroemer & Lorenzo Galluzzi. (2016) Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors. Oncotarget 8:4, pages 5686-5691.
Crossref
Daniel Delitto, Shannon M. Wallet & Steven J. Hughes. (2016) Targeting tumor tolerance: A new hope for pancreatic cancer therapy?. Pharmacology & Therapeutics 166, pages 9-29.
Crossref
Antonius Steven, Scott A. Fisher & Bruce W. Robinson. (2016) Immunotherapy for lung cancer. Respirology 21:5, pages 821-833.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.